MARKET

UPB

UPB

UpStream Bio Inc.
NASDAQ
6.36
+0.01
+0.16%
After Hours: 6.36 0 0.00% 16:10 06/25 EDT
OPEN
6.32
PREV CLOSE
6.35
HIGH
6.57
LOW
6.28
VOLUME
469.88K
TURNOVER
--
52 WEEK HIGH
33.68
52 WEEK LOW
5.85
MARKET CAP
346.11M
P/E (TTM)
-2.1922
1D
5D
1M
3M
1Y
5Y
1D
Piper Sandler Sticks to Their Buy Rating for Upstream Bio, Inc. (UPB)
TipRanks · 14h ago
10 small-cap U.S. healthcare stocks with the weakest momentum grades
Seeking Alpha · 1d ago
Weekly Report: what happened at UPB last week (0615-0619)?
Weekly Report · 3d ago
Top Executive Makes Strategic Move With Upstream Bio Stock
TipRanks · 06/18 02:10
Upstream Bio management to meet with Piper Sandler
TipRanks · 06/17 20:20
Weekly Report: what happened at UPB last week (0608-0612)?
Weekly Report · 06/15 09:48
Upstream Bio Presents Clinically Meaningful Improvements In Phase 2 VIBRANT Trial On Verekitug
NASDAQ · 06/15 07:39
Reported Sunday, Upstream Bio Presents Phase 2 VIBRANT Data Showing 79% Of Verekitug-Treated CRSwNP Patients Achieved Clinically Meaningful Nasal Polyp Score Improvements Versus 24% On Placebo
Benzinga · 06/15 07:01
More
About UPB
Upstream Bio, Inc. is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. The Company is developing verekitug, the only known antagonist in clinical development, that targets the receptor for thymic stromal lymphopoietin (TSLP), a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases. It has advanced this highly potent monoclonal antibody into separate phase II trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and plans to initiate development in chronic obstructive pulmonary disease. TSLP is a member of a class of epithelial cytokines, also including IL-25 and IL-33, commonly referred to as alarmins. TSLP is primarily produced by epithelial cells, especially in the lung, gastrointestinal tract and skin.

Webull offers UpStream Bio Inc. stock information, including NASDAQ: UPB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, UPB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading UPB stock methods without spending real money on the virtual paper trading platform.